Management of dyspepsia in general practice: An observational study

Quality in Primary Care

Volumn 11, Issue 3, 2003, Pages 173-180

  Krol, Nicole ^a   Van Balen, Jacintha ^b   Hartman, Joliet ^a   Wensing, Michel ^a   Grol, Richard ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

Author keywords

Dyspepsia; General practice; Guideline medical care

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DRUG USE; DYSPEPSIA; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; FACTORIAL ANALYSIS; FEMALE; GASTROINTESTINAL REFLUX; GENERAL PRACTICE; GENERAL PRACTITIONER; HELICOBACTER PYLORI; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREDICTION; PRESCRIPTION; PROSPECTIVE STUDY; RELAPSE; SMOKING CESSATION; STOMACH ULCER;

EID: 0142029133     PISSN: 14791072     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A and Holtmann G (1998) AGA technical review: Evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 114: 582-95.
2. Whitaker MJ, Brun J and Carelli F (1997) Controversy and consensus in the management of upper gastrointestinal disease in primary care. The International Gastro Primary Care Group. International Journal of Clinical Practice 51: 239-43.
3. Adang RP, Ambergen AW, Talmon JL et al. (1996) The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: A study on the clinical presentation of 1,147 patients. Digestion 57: 118-34.
4. Hansen JM, Bytzer P and Schaffalitzky de Muckadell OB (1998) Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scandinavian Journal of Gastroenterology 33: 799-805.
5. Holtmann G, Cain C and Malfertheiner P (1999) Gastric Helicobacter pylori infection accelerates healing of reflux oesophagitis during treatment with the proton pump inhibitor Pantoprazole. Gastroenterology 117: 11-16.
6. Mansi C, Savarino V, Mela GS, Picciotto A, Mele MR and Celle G (1993) Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. American Journal of Gastroenterology 88: 1011-15.
7. Talley NJ, Weaver AL, Tesmer DL and Zinsmeister AR (1993) Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 105: 1378-86.
8. Bytzer P (1998) How should new-onset dyspepsia be managed in general and specialist practice? Baillière's Clinical Gastroenterology 12: 587-99.
9. Meineche-Schmidt V, Rubin G and De Wit NJ (2000) Helicobacter pylori infection: A comparative review of existing management guidelines. Family Practice 17 (Suppl 2): S2-5.
10. Weijnen CF, Numans ME, De Wit NJ et al. (2001) Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: Cross-sectional study. British Medical Journal 323: 71-5.
11. Numans ME, De Wit NJ, Geerdes RHM et al. (1996) NHG-Standaard Maagklachten (eerste herziening). Huisarts en Wetenschap 39: 565-77.
12. Boutet R, Wilcock M and MacKenzie I (1999) Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly. Alimentary Pharmacology and Therapeutics 13: 813-17.
13. Stichting Farmaceutische Kengetallen (2001) Toene-mend gebruik maagzuurremmers. Pharmaceutisch Weekblad 136 (20): 1-2.
14. Wit de NJ, Quartero AO, Zuidhoff PAM and Numans ME (2001) Pharmacotherapy for dyspepsia; Analyses of prescription patterns. Gastroenterology 120 (5) (Suppl 1): A1210.
15. Ziekenfondsraad (2000) Rapport Voorwaarden vergoeding maagzuurremmers. Geneesmiddelen Informatie Project '99. Ziekenfondsraad: Amstelveen.
16. Bashford JN, Norwood J and Chapman SR (1998) Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. British Medical Journal 317: 452-6.
17. Spies TH, Mokkink HG, Vries Robbé de PT and Grol RP (in press) Which data source in clinical performance assessment? The use of patient records, prospective self-recording and external observation compared.
18. Bodger K, Daly MJ and Heatley RV (1996) Prescribing patterns for dyspepsia in primary care: A prospective study of selected general practitioners. Alimentary Pharmacology and Therapeutics 10: 889-95.
19. Martin RM, Lim AG, Kerry SM and Hilton SR (1998) Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care. Alimentary Pharmacology and Therapeutics 12: 797-805.
20. Quartero AO, Numans ME, Post MWM, de Melker RA and de Wit NJ (2002) One-year prognosis of primary care dyspepsia: Predictive value of symptom pattern, H. pylori and GP management. European Journal of Gastroenterology and Hepatology 14: 55-60.
21. Heikkinen M, Pikkarainen P, Takala J and Julkunen R (1996) General practitioners' approach to dyspepsia. Survey of consultation frequencies, treatment, and investigations. Scandinavian Journal of Gastroenterology 31: 648-53.
22. Kurata JH, Nogawa AN, Chen YK and Parker CE (1997) Dyspepsia in primary care: Perceived causes, reasons for improvement, and satisfaction with care. Journal of Family Practice 44: 281-8.
23. Hungin AP, Thomas PR, Bramble MG et al. (1994) What happens to patients following open access gastroscopy? An outcome study from general practice. British Journal of General Practice 44: 519-21.
24. Jones R (1988) What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner 232: 75-8.
25. Hungin AP, Rubin GP, Russell AJ and Convery B (1997) Guidelines for dyspepsia management in general practice using focus groups. British Journal of General Practice 47: 275-9.
26. Agreus L and Talley N (1997) Challenges in managing dyspepsia in general practice. British Medical Journal 315: 1284-8.
27. McColl A, Smith H, White P and Field J (1998) General practitioners' perceptions of the route to evidence based medicine: A questionnaire survey. British Medical Journal 316: 361-5.
28. Cambridge and Huntingdon Health Commission Clinical Guidelines (1996) Guidelines for the Effective Management of Dyspepsia. CHHA: Cambridge. www.jr2.ox.ac.uk/pharmacy/A&O/C&H_HA/Dyspepg.html
29. Barnes J (1997) National guidelines on dyspepsia. Practitioner 241: 39-41.
30. Hunt RH (1996) Habit, prejudice, power and politics: Issues in the conversion of H2-receptor antagonists to over-the-counter use [Editorial]. Canadian Medical Association Journal 154: 49-53.
31. Kalish SC, Bohn RL and Avorn J (1997) Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Medical Care 35: 32-48.
32. Quartero AO, Post MW, Numans ME, de Melker RA and de Wit NJ (1999) What makes the dyspeptic patient feel ill? A cross-sectional survey of functional health status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice. Gut 45: 15-19.
33. Heikkinen M, Pikkarainen P, Takala J, Rasanen H, Julkunen R (1995) Etiology of dyspepsia: Four hundred unselected consecutive patients in general practice. Scandinavian Journal of Gastroenterology 30: 519-23.